首页 > 市场调查报告书 > 医疗设备

生技设备细胞培养

市场调查报告书

商品编码

1588517

细胞培养市场规模、份额、成长分析、按产品、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

Cell Culture Market Size, Share, Growth Analysis, By Product, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月07日 | 出版商:

SkyQuest | 英文 208 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球细胞培养市场规模预计为282亿美元，从2023年的320.1亿美元成长到2031年的881.5亿美元，预计在预测期内（2024-2031年）复合年增长率为13.50%。。

由于人们对其应用的认识不断提高以及研究经费的雄厚，特别是在癌症研究方面，全球细胞培养市场正在经历显着增长。复杂的细胞培养技术的进步进一步增强了这种扩张。体外细胞培养涉及从组织中分离细胞并在排除植物和动物来源的受控环境中培养牠们。这种人工环境经过必需营养素的最佳化，并保持适当的 pH 值、湿度、气体和温度，以促进细胞生长和增殖。用于培养的细胞可以使用酵素或机械萃取方法生长，使研究人员能够使用已建立的细胞株和菌株进行实验。该过程依赖各种设备和消耗品，包括重要的化学物质来建立生长条件。受控的物理化学环境、各种生长因子、荷尔蒙、气体、基材和培养基等关键组件对于高效的细胞培养操作至关重要。总体而言，在技术进步和对生命科学领域研发的日益关注的推动下，该市场呈现出充满希望的趋势。

市场概况
消耗品
- 血清、培养基、试剂
- 媒体
- 无血清培养基
- 经典介质和盐
- 干细胞培养基
- 化学成分确定的培养基
- 专门的培养基
- 其他媒体
- 试剂
- 生长因子
- 补充品
- 缓衝液和化学品
- 细胞分离试剂
- 平衡盐溶液
- 依恋因素和基质因素
- 抗生素/抗真菌药
- 防冻试剂
- 污染检测套件
- 其他试剂
- 狮子山
- 牛
- 牛血清
- 其他动物血清
- 船
- 电池工厂系统/电池堆
- 滚筒/娄瓶
- 烧瓶
- 多孔孔盘
- 培养皿
- 配件
装置
- 反应器
- 常规反应器
- 反应器
- 储存设备
- 冰箱/冷冻库
- 冷冻系统
- 其他设备
- 过滤系统
- 细胞计数器
- 二氧化碳培养箱
- 离心机
- 高压釜
- 显微镜
- 生物安全柜
- 其他辅助设备

细胞培养市场：依应用分类

市场概况
生物製药製造
- 单株抗体生产
- 疫苗生产
- 其他治疗性蛋白质的生产
诊断
组织工程与再生医学
- 细胞/基因治疗
- 其他组织工程及再生医学应用
药物筛检与开发
其他用途

细胞培养市场：依最终用户分类

市场概况
製药和生物技术公司
医院和诊断实验室
研究/学术机构
其他最终用户

细胞培养市场：按地区

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Thermo Fisher Scientific Inc.（US）
Danaher Corporation（US）
Merck KGAA（Germany）
Sartorius AG（Germany）
Corning Incorporated（US）
Fujifilm Holdings Corporation（Japan）
BD（Becton, Dickinson and Company）（US）
Eppendorf SE（Germany）
Lonza（Switzerland）
Getinge AB（Sweden）
Agilent Technologies, Inc.（US）
Himedia Laboratories（India）
Bio-Techne（US）
Miltenyi Biotec（Germany）
Stemcell Technologies（Canada）
Solida Biotech GmbH（Germany）
Caisson Labs Inc.（US）
Promocell GmbH（Germany）
Invivogen（US）
Pan-Biotech（Germany）
Cellexus（UK）
Meissner Filtration Products, Inc.（US）
Adolf Kuhner AG（Switzerland）
Advancion Corporation（US）
Biospherix, Ltd.（US）

简介目录

Product Code: SQMIG35H2257

Global Cell Culture Market size was valued at USD 28.2 billion in 2022 and is poised to grow from USD 32.01 billion in 2023 to USD 88.15 billion by 2031, growing at a CAGR of 13.50% during the forecast period (2024-2031).

The global cell culture market is witnessing significant growth driven by increased awareness regarding its applications and robust funding for research, particularly in cancer studies. This expansion is further bolstered by advancements in sophisticated cell culture technologies. In vitro cell culture involves isolating cells from tissues and nurturing them in a controlled environment devoid of plant or animal sources. This artificial setup is optimized with essential nutrients, maintaining appropriate pH levels, humidity, gases, and temperature to facilitate cell growth and proliferation. Cells for culture can be sourced through enzyme-based or mechanical extraction methods, and researchers can utilize established cell lines or strains for their experiments. The process relies on various instruments and consumables, including chemicals that are critical for establishing the growth conditions. Essential components such as a controlled physico-chemical environment, along with various growth factors, hormones, gases, substrates, and media, are vital for efficient cell culture operations. Overall, the market demonstrates promising trends fueled by technological evolution and a growing emphasis on research development within the life sciences field.

Top-down and bottom-up approaches were used to estimate and validate the size of the global cell culture market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global cell culture Market Segmental Analysis

Global Cell Culture Market is segmented by Product, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Equipment. Based on Application, the market is segmented into Biopharmaceutical Production, Diagnostics, Tissue Engineering & Regenerative Medicine, Drug Screening & Development, and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research & Academic Institutes, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the global cell culture Market

The surge in demand for biopharmaceuticals, particularly cell-based therapies and monoclonal antibodies, is a significant market driver for the global cell culture market. This trend is largely influenced by the rising prevalence of chronic diseases, including diabetes, cancer, and autoimmune disorders, which require advanced therapeutic solutions. As a result, the pharmaceutical industry increasingly relies on sophisticated cell culture techniques for large-scale production, research, and development of these biologics. This growing need for effective treatment options not only propels innovation in cell culture technologies but also expands the market, fostering investments and advancements in the sector to meet regulatory and production demands.

Restraints in the global cell culture Market

The global cell culture market faces significant restraints due to ethical concerns surrounding the use of stem cells and animal-derived components in research and product development. These ethical dilemmas are particularly pronounced in regions with stringent regulatory frameworks, where compliance can become an onerous process that stifles innovation. The necessity to navigate complex regulations not only complicates the approval of cell-based products but also hinders the entry of new players into the market. As a result, these challenges can limit the overall growth potential of the cell culture market, leading to reduced investment and slower advancements in biotechnological applications.

Market Trends of the global cell culture Market

The global cell culture market is experiencing a significant shift towards 3D cell culture systems, reflecting a growing preference for models that more accurately mimic in vivo conditions compared to traditional 2D systems. This trend is revolutionizing drug discovery, cancer research, and toxicity testing by enhancing the physiological relevance of experimental results. As stakeholders seek improved efficacy in therapeutic development and better human tissue modeling, the adoption of 3D technologies is projected to accelerate. With advancing biotechnologies and increasing investments in research and development, the market is poised for robust growth, solidifying 3D cell culture as a critical component in biomedical research and pharmaceutical innovation.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Pricing Analysis
Technology Analysis
Patent Analysis
Value Chain Analysis
Supply Chain Analysis
Regulatory Landscape
Customer & Buying Criteria Analysis

Cell Culture Market by Product

Market Overview
Consumables
- Sera, Media, and Reagents
- Media
- Serum-Free Media
- Classical Media & Salts
- Stem Cell Culture Media
- Chemically Defined Media
- Specialty Media
- Other Media
- Reagents
- Growth Factors
- Supplements
- Buffers & Chemicals
- Cell Dissociation Reagents
- Balanced Salt Solutions
- Attachment & Matrix Factors
- Antibiotics/Antimycotics
- Cryoprotective Reagents
- Contamination Detection Kits
- Other Reagents
- Sera
- Fetal Bovine Sera
- Adult Bovine Sera
- Other Animal Sera
- Vessels
- Cell Factory Systems/Cell Stacks
- Roller/Roux Bottles
- Flasks
- Multiwell Plates
- Petri Dishes
- Accessories
Equipment
- Bioreactors
- Conventional Bioreactors
- Single-Use Bioreactors
- Storage Equipment
- Refrigerators & Freezers
- Cryostorage Systems
- Other Equipment
- Filtration Systems
- Cell Counters
- Carbon Dioxide Incubators
- Centrifuges
- Autoclaves
- Microscopes
- Biosafety Cabinets
- Other Supporting Equipment

Cell Culture Market by Application

Market Overview
Biopharmaceutical Production
- Monoclonal Antibody Production
- Vaccine Production
- Other Therapeutic Protein Production
Diagnostics
Tissue Engineering & Regenerative Medicine
- Cell & Gene Therapy
- Other Tissue Engineering & Regenerative Medicine Applications
Drug Screening & Development
Other Applications

Cell Culture Market by End User

Market Overview
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Research & Academic Institutes
Other End Users

Cell Culture Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGAA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eppendorf SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Himedia Laboratories (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stemcell Technologies (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Solida Biotech GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Caisson Labs Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promocell GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invivogen (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pan-Biotech (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellexus (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meissner Filtration Products, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Adolf Kuhner AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advancion Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biospherix, Ltd. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments